We are live on
!
Find out more
HWAM
Hennion & Walsh Asset Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
41.95%
This Fund
S&P 500
This Quarter
Est. Return
+21.43%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$3.5B
AUM Growth
+$531M
(+18%)
Cap. Flow
+$136M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
16.73%
Holding
1,018
New
90
Increased
485
Reduced
375
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$43.2M |
| 2 |
AIVC
Amplify Bloomberg AI Equal Weight ETF
AIVC
|
+$20.8M |
| 3 |
Avantis International Equity ETF
AVDE
|
+$18.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$10.2M |
| 5 |
Invesco S&P International Developed Momentum ETF
IDMO
|
+$7.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$40.2M |
| 2 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$34M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$22.1M |
| 4 |
Celcuity
CELC
|
+$9.49M |
| 5 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$7.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.69% |
| 2 | Healthcare | 10.37% |
| 3 | Industrials | 9.1% |
| 4 | Financials | 7.52% |
| 5 | Utilities | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Blackrock
BLK
$164B
| $4.13M | 0.12% |
4,300
+136
| +3% | +$141K |
|
227
CMS Energy
CMS
$23.1B
| $4.08M | 0.12% |
53,371
+4,297
| +9% | +$322K |
|
|
FLC
228
Flaherty & Crumrine Total Return Fund
FLC
$174M
| $4.08M | 0.12% |
241,468
+42,263
| +21% | +$715K |
|
229
Stryker
SYK
$127B
| $4.04M | 0.12% |
12,844
+501
| +4% | +$158K |
|
230
Intuitive Surgical
ISRG
$121B
| $3.99M | 0.11% |
10,025
+244
| +2% | +$107K |
|
231
Royal Caribbean
RCL
$78.7B
| $3.98M | 0.11% |
12,527
-469
| -4% | -$131K |
|
232
Boston Scientific
BSX
$65.8B
| $3.97M | 0.11% |
93,021
-12,885
| -12% | -$700K |
|
233
Corcept Therapeutics
CORT
$10.2B
| $3.95M | 0.11% |
45,429
-550
| -1% | -$33.2K |
|
234
Travelers Companies
TRV
$80.8B
| $3.93M | 0.11% |
11,916
+205
| +2% | +$62.1K |
|
235
V2X
VVX
$2.62B
| $3.86M | 0.11% |
51,815
-6,664
| -11% | -$496K |
|
236
Equinix
EQIX
$107B
| $3.85M | 0.11% |
3,697
+439
| +13% | +$470K |
|
237
Blue Owl Capital
OBDC
$5.35B
| $3.84M | 0.11% |
353,588
-21,565
| -6% | -$241K |
|
238
Viridian Therapeutics
VRDN
$2.13B
| $3.84M | 0.11% |
209,092
+34,198
| +20% | +$551K |
|
239
Kinder Morgan
KMI
$73.1B
| $3.83M | 0.11% |
119,663
+14,932
| +14% | +$481K |
|
240
ProKidney
PROK
$308M
| $3.77M | 0.11% |
1,847,749
+236,056
| +15% | +$432K |
|
|
AGD
241
abrdn Global Dynamic Dividend Fund
AGD
$315M
| $3.76M | 0.11% |
310,171
+3,715
| +1% | +$45.2K |
|
242
Intellia Therapeutics
NTLA
$1.5B
| $3.73M | 0.11% |
220,523
+60,720
| +38% | +$850K |
|
243
Gabelli Dividend & Income Trust
GDV
$2.6B
| $3.72M | 0.11% |
126,603
+11,628
| +10% | +$336K |
|
244
Invesco Quality Municipal Securities
IQI
$526M
| $3.72M | 0.11% |
367,504
-447,216
| -55% | -$4.41M |
|
245
Nuveen New York Municipal Value Fund
NNY
$158M
| $3.62M | 0.1% |
414,691
-8,114
| -2% | -$69.5K |
|
246
Kratos Defense & Security Solutions
KTOS
$8.88B
| $3.62M | 0.1% |
72,660
+2,808
| +4% | +$170K |
|
247
Kroger
KR
$34.8B
| $3.61M | 0.1% |
65,002
+1,141
| +2% | +$74.4K |
|
248
Gilead Sciences
GILD
$161B
| $3.6M | 0.1% |
28,507
+1,235
| +5% | +$163K |
|
249
Huntington Ingalls Industries
HII
$11.3B
| $3.57M | 0.1% |
12,752
+1,469
| +13% | +$491K |
|
250
Phathom Pharmaceuticals
PHAT
$912M
| $3.55M | 0.1% |
327,278
+181,346
| +124% | +$2.07M |
|
Similar funds
TCM
BCP
ACA
TH
DILIC
TYCC
KCM
ACM
Hennion & Walsh Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Hennion & Walsh Asset Management held 1,018 positions worth $3.5B, up 18% from $2.97B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Hennion & Walsh Asset Management deployed $136M of net new capital in Q2 2026, opening 90 new positions and adding to 485 existing holdings. Its largest new stake was BlackRock US Equity Factor Rotation ETF: 664,010 shares worth $45.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, an estimated $40.2M trimmed.
- Hennion & Walsh Asset Management's largest Q2 2026 buy was BlackRock US Equity Factor Rotation ETF: 664,010 shares worth $45.2M.
- Hennion & Walsh Asset Management added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $10.2M increase.
- Hennion & Walsh Asset Management's biggest Q2 2026 reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, cutting an estimated $40.2M.
- Hennion & Walsh Asset Management fully exited Invesco S&P 500 Equal Weight ETF in Q2 2026, selling an estimated $22.1M.
- Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $3.5B portfolio in Q2 2026.
- Hennion & Walsh Asset Management opened 90 new positions and closed 63 in Q2 2026.
- Hennion & Walsh Asset Management's portfolio value rose 18% quarter-over-quarter to $3.5B.
Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.